Dogtown Media Co-Founder Marc Fischer to Speak at AAN Annual Meeting on NeurCare and the Future of Remote Monitoring of Neurological PatientsApril 26, 2023 - 4 minutes read
We are thrilled to announce that Marc Fischer, CEO and Co-Founder of Dogtown Media, will be speaking at the prestigious 75th American Academy of Neurology (AAN) Annual Meeting, taking place from April 22-27, 2023. The event will be held in a hybrid format, offering participants the option to attend in person in Boston or to participate live online. The AAN Annual Meeting is renowned for its diverse offerings, top-tier education, and cutting-edge science in the field of neurology, attracting medical professionals and experts from around the world.
NeurCare App: Revolutionizing Remote Monitoring for Neurological Patients
Marc Fischer will present on NeurCare, our groundbreaking mHealth app designed to remotely monitor patients with neurological disorders and provide early detection of neurotoxicity due to CAR T-Cell immunotherapy treatments. His session, titled “Remote Monitoring of Neurological Patients,” will take place on Thursday, April 27th at 11:45 AM EST, both in-person and online.
The presentation will delve into the global shortage of neurologists and the impact of COVID-related restrictions on patient care. To address this gap in care, Dogtown Media collaborated with the National Institutes of Health (NIH) to develop NeurCare, a self-administered mobile app that can remotely monitor a patient’s condition.
Tackling the Global Shortage of Neurologists with mHealth Solutions
In his talk, Marc Fischer will discuss the long-term goal of employing smartphone-embedded sensors to measure various neurological functions in a patient-autonomous manner, thereby reducing the need for in-person consultations and easing the burden on healthcare providers. He will also share insights into the development process of the NeurCare app, including the challenges faced and lessons learned while creating an intuitive, user-friendly tool for both patients and healthcare providers.
The session will cover the testing and validation of NeurCare, providing an in-depth look at the app’s performance in detecting and characterizing clinical manifestations of neurological disorders. Marc will discuss the app’s accuracy in assessing variations in handwriting, such as micrographia, dysgraphia, and agraphia, and its potential to serve as a valuable tool for physicians and healthcare providers in monitoring patients remotely.
The NeurCare app has already received recognition as an awardee in the Improving Detection of Neurotoxicity in Immunotherapies QuickFire Challenge by Johnson & Johnson Innovation LLC. This award highlights the potential of NeurCare to improve patient outcomes and reduce healthcare costs by enabling early detection of neurotoxic events in patients undergoing immunotherapies within the hematologic malignancy space.
Dogtown Media’s Commitment to Healthcare Innovation and Improved Patient Outcomes
We are proud to have Marc Fischer represent Dogtown Media at the AAN Annual Meeting, showcasing our commitment to addressing critical healthcare challenges through innovative technology solutions. The NeurCare app is just one example of our dedication to improving patient outcomes and advancing the field of neurology. As a leader in mHealth app development, Dogtown Media continues to explore new ways to leverage technology in enhancing patient care and transforming the healthcare landscape.
If you’re attending the AAN Annual Meeting, be sure to catch Marc Fischer’s presentation on NeurCare and the future of remote monitoring of neurological patients. This session promises to offer valuable insights into the role of technology in addressing the challenges faced by patients and healthcare providers in the neurology field. Don’t miss this opportunity to learn from our mHealth app development experience and to discover how NeurCare is shaping the future of patient care in neurology.Tags: healthcare medical app, mhealth app, mHealth app developer, mHealth app development, NeurCare